Levocetirizine Dihydrochloride
The active substance of Cezera is levocetirizine dihydrochloride.
Cezera is an antiallergic medication.
Cezera is used to treat symptoms associated with:
Before taking Cezera, discuss it with your doctor or pharmacist.
If you may have difficulty emptying your bladder (in conditions such as spinal cord injury or prostate enlargement), consult your doctor.
Cezera may exacerbate seizure attacks, so consult your doctor if you have epilepsy or a risk of seizures.
If you are scheduled to undergo allergy testing, ask your doctor if you should stop taking Cezera a few days before the test. The medicine may affect the results of allergy tests.
Cezera film-coated tablets are not recommended for children under 6 years of age, as it is not possible to adjust the dose appropriately for this form of the medicine.
Tell your doctor or pharmacist about all medicines you are taking, have recently taken, or might take.
Be cautious when taking Cezera with alcohol or other substances that affect brain function.
In sensitive patients, taking Cezera with alcohol or other substances that affect brain function may cause additional decreased alertness and reaction ability.
Cezera can be taken with or without food.
If you are pregnant, breastfeeding, or think you may be pregnant, consult your doctor or pharmacist before taking this medicine.
Some patients taking Cezera may experience drowsiness and (or) fatigue, tiredness, and exhaustion. Be cautious when driving or operating machinery until you know how the medicine affects you. However, special tests conducted in healthy individuals did not show any impairment of concentration, reaction ability, or driving ability after taking levocetirizine at the recommended dose.
If you have been diagnosed with an intolerance to some sugars, consult your doctor before taking the medicine.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
The recommended dose for adults and children over 6 years is one tablet per day.
Kidney and Liver Impairment
In patients with kidney impairment, the dose of Cezera may be reduced depending on the degree of kidney impairment. In children, the dose should also be adjusted according to body weight; the doctor will determine the dose of the medicine.
Cezera should not be taken by patients with severe kidney disease requiring dialysis.
Patients with only liver impairment should take the usual dose.
In patients with both kidney and liver impairment, the dose of Cezera may be reduced depending on the degree of kidney impairment, and in children, the dose will also be adjusted according to body weight; the doctor will determine the dose of the medicine.
Elderly Patients (65 Years and Over)
No dose adjustment is necessary for elderly patients with normal kidney function.
Cezera is not recommended for children under 6 years of age.
Cezera is for oral use only.
Swallow the tablets whole with water. The tablets can be taken with or without food.
The duration of treatment depends on the type, duration, and severity of the disease symptoms and is determined by the doctor.
In adults, if a higher dose of Cezera is taken than recommended, drowsiness may occur.
In children, initial excitement and restlessness may occur, followed by drowsiness.
If you take more Cezera than you should, contact your doctor, who will decide what actions to take.
If you miss a dose of Cezera or take a lower dose than recommended by your doctor, do not take a double dose to make up for the missed dose. Instead, take the next dose at the usual time.
Stopping Cezera treatment should not cause any harmful effects. However, in rare cases, itching (intense itching) may occur after stopping Cezera treatment, even if these symptoms did not occur before starting treatment. These symptoms may resolve on their own. In some cases, these symptoms may be intense and may require restarting treatment. These symptoms should resolve after restarting treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Cezera can cause side effects, although not everybody gets them.
Dry mouth, headache, fatigue, drowsiness, and (or) somnolence.
Exhaustion, abdominal pain.
Other side effects have also been reported, such as: palpitations, increased heart rate, seizure attacks, tingling and numbness, dizziness, fainting, tremors, taste disturbances (altered taste perception), feeling of spinning or swaying, vision disturbances, blurred vision, rotational eye movements (uncontrolled circular eye movement), painful or difficult urination, inability to fully empty the bladder, edema, itching, rash, urticaria (swelling, redness, and itching of the skin), skin eruptions, shortness of breath, weight gain, muscle pain, joint pain, aggression or excitement, hallucinations, depression, insomnia, recurrent suicidal thoughts or morbid preoccupation with suicide, nightmares, hepatitis, abnormal liver function test results, vomiting, increased appetite, nausea, and diarrhea. Itching (intense itching) after stopping Cezera treatment.
If you experience the first symptoms of a hypersensitivity reaction, stop taking Cezera immediately and contact your doctor. Symptoms of a hypersensitivity reaction may include: swelling of the mouth, tongue, face, and (or) throat, breathing or swallowing difficulties (chest tightness or wheezing), urticaria, sudden decrease in blood pressure leading to collapse or shock, which can be fatal.
If you experience any side effects, including those not listed in this leaflet, please inform your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products:
Aleje Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help to gather more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after "EXP". The expiry date refers to the last day of that month.
The batch number is stated on the packaging after "Lot".
There are no special storage precautions.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The tablets are film-coated, white, round, biconvex with beveled edges.
Packaging:20, 28, 30, and 90 film-coated tablets in blisters in a cardboard box
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
KRKA, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
TAD Pharma GmbH, Heinz-Lohmann-Straße 5, 27472 Cuxhaven, Germany
To obtain more detailed information on the names of medicinal products in other EU member states, please contact the representative of the marketing authorization holder:
KRKA-POLSKA Sp. z o.o.
ul. Równoległa 5
02-235 Warsaw
Phone: 22 57 37 500
Date of Last Revision of the Leaflet:14.03.2024
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.